What percentage of adult males with nocturia (nocturnal urination) also have sleep apnea (obstructive sleep apnea syndrome)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prevalence of Sleep Apnea in Males with Nocturia

Approximately 75-80% of adult males with nocturia have obstructive sleep apnea, with the association being strongest in men under 50 years of age. 1, 2

Evidence from Clinical Studies

Overall Prevalence Data

  • In a landmark polysomnography study of 80 consecutive patients with nocturia (awakening at least once to urinate), 79.3% of awakenings were directly caused by sleep apnea, snoring, or periodic leg movements rather than bladder pressure. 2

  • Among 1,757 men referred for sleep evaluation, nocturia frequency correlated significantly with the apnea-hypopnea index (AHI), though this relationship was modified by age. 3

  • In a prospective study of 274 OSAS patients treated with CPAP, 76.4% reported at least one nocturia episode before treatment, with 73.0% experiencing clinically relevant nocturia (≥2 voids per night). 4

Age-Specific Patterns

The relationship between sleep apnea and nocturia is particularly strong in younger men:

  • In men under 50 years of age, the AHI was significantly higher in those with nocturia compared to those without (P <0.005), and nocturia occurred without other voiding symptoms, suggesting OSA as the primary cause. 5

  • Multiple regression analysis in men <65 years showed that AHI independently predicted pathological nocturia (OR 1.02, P <0.001), along with age and benign prostatic hypertrophy. 3

  • However, in men ≥65 years, sleep apnea parameters showed no significant relationship with nocturia frequency, as age-related urinary diseases and voiding dysfunction override the influence of OSA. 3

Clinical Phenotype Characteristics

Males with both nocturia and OSA represent a distinct phenotype of more severe disease:

  • Nocturic OSA patients had significantly higher AHI (64.8 ± 35.9 vs. 43.9 ± 29.1; P <0.001), higher Epworth Sleepiness Scale scores (9.2 ± 5.3 vs. 7.7 ± 4.4), and lower nadir oxygen saturation during sleep. 6

  • A history of nocturia (≥2 voids/night) increased the odds of very severe OSA (AHI >60) by 2.4 times (95% CI 1.086-5.434, P = 0.031). 6

  • Time between bedtime and first urination was significantly shorter in very severe OSA (2.4 ± 0.9 hours) compared to severe OSA (3.1 ± 1.3 hours) and mild-to-moderate OSA (3.0 ± 1.1 hours). 6

Diagnostic Pitfall: Patient Misattribution

A critical clinical caveat is that patients are extremely poor judges of why they awaken to urinate:

  • Patients correctly identified the source of their awakening in only 4.9% of cases, with sleep apnea correctly cited only once out of 121 awakenings. 2

  • The fact that patients urinate once awake contributes to faulty post hoc reasoning, leading both patients and physicians to incorrectly attribute awakenings to bladder pressure rather than sleep-disordered breathing. 2

  • The American Geriatrics Society recognizes nocturia as a symptom of OSA, along with excessive daytime sleepiness, snoring, observed apnea, and morning headache. 1

Treatment Response

CPAP treatment significantly reduces nocturia in males with OSA:

  • Treatment with CPAP reduced nocturia by one or more episodes per night in 42.3% of patients, with clinically relevant nocturia (≥2 voids/night) decreasing from 73.0% to 51.5%. 4

  • This reduction occurred in both sexes without statistically significant gender differences. 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.